281 related articles for article (PubMed ID: 31492960)
1. Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease.
Carvajal S; Perramón M; Oró D; Casals E; Fernández-Varo G; Casals G; Parra M; González de la Presa B; Ribera J; Pastor Ó; Morales-Ruíz M; Puntes V; Jiménez W
Sci Rep; 2019 Sep; 9(1):12848. PubMed ID: 31492960
[TBL] [Abstract][Full Text] [Related]
2. Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis.
Oró D; Yudina T; Fernández-Varo G; Casals E; Reichenbach V; Casals G; González de la Presa B; Sandalinas S; Carvajal S; Puntes V; Jiménez W
J Hepatol; 2016 Mar; 64(3):691-8. PubMed ID: 26519601
[TBL] [Abstract][Full Text] [Related]
3. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
[TBL] [Abstract][Full Text] [Related]
4. Beyond the Scavenging of Reactive Oxygen Species (ROS): Direct Effect of Cerium Oxide Nanoparticles in Reducing Fatty Acids Content in an In Vitro Model of Hepatocellular Steatosis.
Parra-Robert M; Casals E; Massana N; Zeng M; Perramón M; Fernández-Varo G; Morales-Ruiz M; Puntes V; Jiménez W; Casals G
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31470518
[TBL] [Abstract][Full Text] [Related]
5. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats.
Hussein O; Grosovski M; Lasri E; Svalb S; Ravid U; Assy N
World J Gastroenterol; 2007 Jan; 13(3):361-8. PubMed ID: 17230603
[TBL] [Abstract][Full Text] [Related]
6. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
Jeong MJ; Kim SR; Jung UJ
Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
8. Cerium Oxide Nanoparticles Protect against Oxidant Injury and Interfere with Oxidative Mediated Kinase Signaling in Human-Derived Hepatocytes.
Carvajal S; Perramón M; Casals G; Oró D; Ribera J; Morales-Ruiz M; Casals E; Casado P; Melgar-Lesmes P; Fernández-Varo G; Cutillas P; Puntes V; Jiménez W
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783479
[TBL] [Abstract][Full Text] [Related]
9. L-carnitine supplementation attenuates NAFLD progression and cardiac dysfunction in a mouse model fed with methionine and choline-deficient diet.
Mollica G; Senesi P; Codella R; Vacante F; Montesano A; Luzi L; Terruzzi I
Dig Liver Dis; 2020 Mar; 52(3):314-323. PubMed ID: 31607566
[TBL] [Abstract][Full Text] [Related]
10. Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model.
Rein-Fischboeck L; Haberl EM; Pohl R; Schmid V; Feder S; Krautbauer S; Liebisch G; Buechler C
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):526-537. PubMed ID: 29474931
[TBL] [Abstract][Full Text] [Related]
11. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
[TBL] [Abstract][Full Text] [Related]
12. Ginkgolide A ameliorates non-alcoholic fatty liver diseases on high fat diet mice.
Jeong HS; Kim KH; Lee IS; Park JY; Kim Y; Kim KS; Jang HJ
Biomed Pharmacother; 2017 Apr; 88():625-634. PubMed ID: 28142119
[TBL] [Abstract][Full Text] [Related]
13. The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model.
Tzeng TF; Tzeng YC; Cheng YJ; Liou SS; Liu IM
Nutrients; 2015 Oct; 7(10):8670-84. PubMed ID: 26506376
[TBL] [Abstract][Full Text] [Related]
14. Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion.
de Oliveira PR; da Costa CA; de Bem GF; Cordeiro VS; Santos IB; de Carvalho LC; da Conceição EP; Lisboa PC; Ognibene DT; Sousa PJ; Martins GR; da Silva AJ; de Moura RS; Resende AC
PLoS One; 2015; 10(12):e0143721. PubMed ID: 26630290
[TBL] [Abstract][Full Text] [Related]
15. The Ameliorating Effects of n-3 Polyunsaturated Fatty Acids on Liver Steatosis Induced by a High-Fat Methionine Choline-Deficient Diet in Mice.
Šmíd V; Dvořák K; Stehnová K; Strnad H; Rubert J; Stříteský J; Staňková B; Stránská M; Hajšlová J; Brůha R; Vítek L
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139055
[TBL] [Abstract][Full Text] [Related]
16. Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease.
Korish AA; Arafah MM
BMC Complement Altern Med; 2013 Oct; 13():264. PubMed ID: 24119413
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.
Ali MH; Messiha BA; Abdel-Latif HA
Pharm Biol; 2016 Jul; 54(7):1198-208. PubMed ID: 26134756
[TBL] [Abstract][Full Text] [Related]
18. Ameliorative Effect of Spinach on Non-Alcoholic Fatty Liver Disease Induced in Rats by a High-Fat Diet.
Elvira-Torales LI; Martín-Pozuelo G; González-Barrio R; Navarro-González I; Pallarés FJ; Santaella M; García-Alonso J; Sevilla Á; Periago-Castón MJ
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987167
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.
Schröder T; Kucharczyk D; Bär F; Pagel R; Derer S; Jendrek ST; Sünderhauf A; Brethack AK; Hirose M; Möller S; Künstner A; Bischof J; Weyers I; Heeren J; Koczan D; Schmid SM; Divanovic S; Giles DA; Adamski J; Fellermann K; Lehnert H; Köhl J; Ibrahim S; Sina C
Mol Metab; 2016 Apr; 5(4):283-295. PubMed ID: 27069868
[TBL] [Abstract][Full Text] [Related]
20. Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis.
Macfarlane DP; Zou X; Andrew R; Morton NM; Livingstone DE; Aucott RL; Nyirenda MJ; Iredale JP; Walker BR
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E402-9. PubMed ID: 21119028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
